The Scientist - Home

President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.

The study aims to recruit 40,000 adults and children to get a better sense of the condition that can last weeks or months after infection.

The results reveal evolutionary relatives of the Cas9 enzyme now used extensively in biotechnology.

Worms, flies, and yeast live longer if the fidelity of their protein-making machinery is improved, a study shows.

Ethologist Jan Langbein and his team trained the cattle as a way to keep solid and liquid cattle waste separate—with the goal of reducing ammonia emissions coming from livestock.

A full beard can absorb nearly 40 percent of the shock from a punch to the face, according to one winning study.

Some Louisiana research centers lost samples and reagents, and with power only just now being restored, there’s a long road ahead to full recovery.

Mice lacking irisin didn’t exhibit the cognition improvements that typically follow exercise, and in mouse models of Alzheimer’s disease, treatment with the hormone reduced cognitive decline.

Many scientists have turned to preprints to rapidly disseminate their research on COVID-19, but some disagree with this approach.

A new platform enables screening a wide range of combination anticancer therapeutics in a matter of days, which may translate to personalized therapeutic regimens for patients in less time.

A newly developed platform may one day replace cell culture and animal models to personalize cancer treatment.

Heated gold nanoparticles unleash the therapeutic activity of engineered CAR T cells.